Assessment of Pivka II as Tumour Marker in Hepatocellular Carcinoma
Real impact of tumor marker AFP and PIVKA-II in detecting very small hepatocellular carcinoma (≤ 2 cm, Barcelona stage 0) - assessment with large number of cases
Premium Photo | Pivka ii or protein induced by vitamin k ii test a screening marker for hepatocellular carcinoma
Outcomes of patients presenting with elevated tumor marker levels but negative gadoxetic acid-enhanced liver MRI after a complete response to hepatocellular carcinoma treatment | PLOS ONE
Elecsys® PIVKA-II
The Relationship between Serum PIVKA-II Levels and the Severity of... | Download Table
PIVKA-II serves as a potential biomarker that complements AFP for the diagnosis of hepatocellular carcinoma | BMC Cancer | Full Text
Efficacy of PIVKA-II in prediction and early detection of hepatocellular carcinoma: a nested case-control study in Chinese patients | Scientific Reports
Clinical evaluation of Elecsys PIVKA-II for patients with advanced hepatocellular carcinoma | PLOS ONE
The diagnostic performance of PIVKA-II in metabolic and viral hepatocellular carcinoma: a pilot study
PIVKA-II, a biomarker of liver cells for the management of hepatocellular carcinoma (HCC) | Fujirebio
IJMS | Free Full-Text | Immunological Markers, Prognostic Factors and Challenges Following Curative Treatments for Hepatocellular Carcinoma
Frontiers | Progression of Prothrombin Induced by Vitamin K Absence-II in Hepatocellular Carcinoma
Real impact of tumor marker AFP and PIVKA-II in detecting very small hepatocellular carcinoma (≤ 2 cm, Barcelona stage 0) - assessment with large number of cases
Distribution, levels and diagnostic value of PIVKA-II in HCC patients.... | Download Scientific Diagram
PIVKA-II serves as a potential biomarker that complements AFP for the diagnosis of hepatocellular carcinoma | BMC Cancer | Full Text
Value of AFP and PIVKA-II in diagnosis of HBV-related hepatocellular carcinoma and prediction of vascular invasion and tumor differentiation | Infectious Agents and Cancer | Full Text
Clinical value of serum AFP and PIVKA‐II for diagnosis, treatment and prognosis of hepatocellular carcinoma - Tian - Journal of Clinical Laboratory Analysis - Wiley Online Library
Pivka-II Monoclonal Antibody (DCP tumor marker) - China Pivka-II, Antibody | Made-in-China.com
Significance of PIVKA‑II levels for predicting microvascular invasion and tumor cell proliferation in Chinese patients with hepatitis B virus‑associated hepatocellular carcinoma
PIVKA-II is a candidate marker for monitoring the effects of the oral anticoagulant warfarin. | Semantic Scholar
pivka_ii_pair_recommendations_1.jpg
Clinical utility of PIVKA-II in the diagnosis of hepatocellular carcinoma - Clinical Laboratory int.
The value of PIVKA-Ⅱ versus AFP for the diagnosis and detection of postoperative changes in hepatocellular carcinoma - ScienceDirect
